11-β hydroxysteroid type 1 knockout mice display an antidepressant-like phenotype in the forced swim test

David A Slattery1, Doncho P Uzunov1, John F Cryan1

  • 11Neuroscience Research,Novartis Institutes for BioMedical Research,Novartis Pharma AG,Basel,Switzerland.

Acta Neuropsychiatrica
|September 25, 2015
PubMed
Abstract

Insights

Genetic knockout of 11 beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) shows antidepressant-like effects in mice. This suggests 11β-HSD1 plays a role in depression-related behaviors.

Area of Science:

  • Neuroscience
  • Endocrinology
  • Pharmacology

Background:

  • 11 beta-hydroxysteroid dehydrogenase (HSD) enzymes regulate glucocorticoid activity.
  • 11β-HSD1 activates glucocorticoids, while 11β-HSD2 inactivates them.
  • Previous indirect evidence linked these enzymes to depression etiology.

Purpose of the Study:

  • To directly investigate the role of 11β-HSD1 in depression-related behaviors using animal models.
  • To assess the effect of 11β-HSD1 gene ablation on behavioral tests indicative of antidepressant activity.

Main Methods:

  • Utilized 11β-HSD1 knockout mice.
  • Assessed behavioral phenotypes using the forced swim test (FST) and tail suspension test (TST).
  • Measured locomotor activity to control for general motor function.

Main Results:

  • Genetic deletion of 11β-HSD1 resulted in an antidepressant-like phenotype in the FST.
  • No significant antidepressant-like effect was observed in the TST.
  • The observed behavioral changes were not attributable to alterations in general locomotor activity.

Conclusions:

  • 11β-HSD1 appears to play a significant role in depression-related behaviors.
  • Further research is warranted to fully elucidate the function of 11β-HSD1 in these behaviors.
  • Findings suggest 11β-HSD1 as a potential therapeutic target for depression.

Related Concept Videos